SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001636050-21-000079
Filing Date
2021-10-06
Accepted
2021-10-06 17:18:54
Documents
4
Effectiveness Date
2021-10-06

Document Format Files

Seq Description Document Type Size
1 S-8 sioxs-82021.htm S-8 84927
2 EX-5.1 sioxs-82021exx51.htm EX-5.1 11166
3 EX-23.1 sioxs-82021exx231.htm EX-23.1 2725
4 GRAPHIC cooley1a.jpg GRAPHIC 8359
  Complete submission text file 0001636050-21-000079.txt   111751
Mailing Address 130 WEST 42ND STREET 26TH FLOOR NEW YORK NY 10036
Business Address 130 WEST 42ND STREET 26TH FLOOR NEW YORK NY 10036 877-746-4891
Sio Gene Therapies Inc. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 853863315 | Fiscal Year End: 0331
Type: S-8 | Act: 33 | File No.: 333-260100 | Film No.: 211310435
SIC: 2834 Pharmaceutical Preparations